HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jan L Cohen Selected Research

(E)- 4- (2- (2- (N- acetyl- N- (4- methoxybenzenesulfonyl)amino)stilbazole)) 1-oxide

9/2006A phase I pharmacokinetic study of HMN-214, a novel oral stilbene derivative with polo-like kinase-1-interacting properties, in patients with advanced solid tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jan L Cohen Research Topics

Disease

1Neoplasms (Cancer)
09/2006
1Pain (Aches)
09/2006
1Pancreatic Neoplasms (Pancreatic Cancer)
09/2006
1Colorectal Neoplasms (Colorectal Cancer)
09/2006

Drug/Important Bio-Agent (IBA)

1(E)- 4- (2- (2- (N- acetyl- N- (4- methoxybenzenesulfonyl)amino)stilbazole)) 1-oxideIBA
09/2006
1Carcinoembryonic AntigenIBA
09/2006
1StilbenesIBA
09/2006

Therapy/Procedure

1Drug Tapering
09/2006